tiprankstipranks
Advertisement
Advertisement

HK:2696 Stock Latest News

Henlius Shareholders Unanimously Approve 2025 Reports and Profit Distribution
Company AnnouncementsHenlius Shareholders Unanimously Approve 2025 Reports and Profit Distribution
2d ago
2696
Henlius Wins Australian Nod for First-in-Class Bispecific Cancer ADC Trial
PremiumCompany Announcements
Henlius Wins Australian Nod for First-in-Class Bispecific Cancer ADC Trial
8d ago
2696
Henlius Starts First-in-Human Trial of Novel KAT6A/B Inhibitor HLX97 in Advanced Tumours
PremiumCompany Announcements
Henlius Starts First-in-Human Trial of Novel KAT6A/B Inhibitor HLX97 in Advanced Tumours
8d ago
2696
Henlius Wins EU Approval for Two New Serplulimab Cancer Uses
PremiumCompany Announcements
Henlius Wins EU Approval for Two New Serplulimab Cancer Uses
11d ago
2696
Henlius Wins FDA Nod to Begin U.S. Trial of Cetuximab Biosimilar HLX05-N
PremiumCompany Announcements
Henlius Wins FDA Nod to Begin U.S. Trial of Cetuximab Biosimilar HLX05-N
11d ago
2696
Henlius Wins Japan Go-Ahead for Global Phase 2/3 Trial of Lung Cancer ADC HLX43
PremiumCompany AnnouncementsHenlius Wins Japan Go-Ahead for Global Phase 2/3 Trial of Lung Cancer ADC HLX43
17d ago
2696
Henlius Starts First-in-Human Trial of Novel Tetra-Specific Cancer Antibody HLX3901
Premium
Company Announcements
Henlius Starts First-in-Human Trial of Novel Tetra-Specific Cancer Antibody HLX3901
21d ago
2696
Henlius Wins EU Nod for Pertuzumab Biosimilar, Expanding Global Oncology Footprint
Premium
Company Announcements
Henlius Wins EU Nod for Pertuzumab Biosimilar, Expanding Global Oncology Footprint
23d ago
2696
Henlius wins Australian nod for global phase 2/3 trial of HLX07 combo in advanced lung cancer
PremiumCompany Announcements
Henlius wins Australian nod for global phase 2/3 trial of HLX07 combo in advanced lung cancer
27d ago
2696
Henlius Sets 2026 AGM to Approve 2025 Results and New Share Issuance Mandate
PremiumCompany Announcements
Henlius Sets 2026 AGM to Approve 2025 Results and New Share Issuance Mandate
27d ago
2696
Henlius Grants New Share Options and RSUs to Align Incentives With Performance
PremiumCompany Announcements
Henlius Grants New Share Options and RSUs to Align Incentives With Performance
1M ago
2696
Henlius Wins NMPA Nod to Start Trials of Cetuximab Biosimilar HLX05-N
PremiumCompany Announcements
Henlius Wins NMPA Nod to Start Trials of Cetuximab Biosimilar HLX05-N
1M ago
2696
Henlius Starts Phase 1 Trial of HLX319, a Subcutaneous Pertuzumab-Trastuzumab Biosimilar in China
PremiumCompany AnnouncementsHenlius Starts Phase 1 Trial of HLX319, a Subcutaneous Pertuzumab-Trastuzumab Biosimilar in China
1M ago
2696
Henlius Wins China Nod to Expand Indications for Rituximab Biosimilar HANLIKANG
Premium
Company Announcements
Henlius Wins China Nod to Expand Indications for Rituximab Biosimilar HANLIKANG
1M ago
2696
Henlius Wins NMPA Nod to Begin Trials of HER2 Breast Cancer Biosimilar HLX319
Premium
Company Announcements
Henlius Wins NMPA Nod to Begin Trials of HER2 Breast Cancer Biosimilar HLX319
2M ago
2696
Henlius Wins NMPA Nod to Start Trials of Novel Hyaluronidase Injection
PremiumCompany Announcements
Henlius Wins NMPA Nod to Start Trials of Novel Hyaluronidase Injection
2M ago
2696
Henlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe
PremiumCompany Announcements
Henlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe
2M ago
2696
Henlius Starts Phase 1b/2 Trial of CD47-Targeting HLX701 in Advanced Colorectal Cancer
PremiumCompany Announcements
Henlius Starts Phase 1b/2 Trial of CD47-Targeting HLX701 in Advanced Colorectal Cancer
2M ago
2696
Henlius Wins NMPA Nod for Phase 1 Trial of Nivolumab Biosimilar HLX18
PremiumCompany Announcements
Henlius Wins NMPA Nod for Phase 1 Trial of Nivolumab Biosimilar HLX18
2M ago
2696
Henlius Boosts 2025 Revenue as Global Drug Approvals Broaden Its Biologic Portfolio
PremiumCompany AnnouncementsHenlius Boosts 2025 Revenue as Global Drug Approvals Broaden Its Biologic Portfolio
2M ago
2696
Henlius Taps Fosun Affiliate to Promote HANBEITAI in Connected-Party Deal
Premium
Company Announcements
Henlius Taps Fosun Affiliate to Promote HANBEITAI in Connected-Party Deal
2M ago
2696
Shanghai Henlius revamps Hong Kong company secretary and governance roles
Premium
Company Announcements
Shanghai Henlius revamps Hong Kong company secretary and governance roles
2M ago
2696

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >